Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Linical and Accelovance recently merged to create a midsized, global contract research organization (CRO) with a footprint across North America, Europe and Asia-Pacific.
read more
I-Mab Biopharma and ABL Bio, jointly announced that two companies had entered into a partnering agreement for ABL Bio to in-license the global rights excluding Greater China to I-Mab's bispecific antibodies of undisclosed target with licensing ...
read more
Under the agreement granting the exclusive right to license the technology, Q BioMed will continue to evaluate the feasibility and usability of GDF15, a novel biomarker for monitoring glaucoma.
read more
Takara Bio announced the MPA has granted a manufacturing license for derivation and banking of human embryonic stem cells to be produced under GMP conditions within Takara Bio Europe's facility.
read more
Sinclair Research has named Scott E. Boley, PhD, DABT, as vice president of toxicology.
read more
Pharmaceutical Product Development has expanded its central lab technology capabilities integrated with Preclarus.
read more
WuXi Biologics announced that the first GMP campaign in the new MFG3 facility was completed successfully.
read more
As part of its ongoing implementation of the Drug Quality and Security Act and to advance the goals of its 2018 Compounding Policy Priorities Plan, the U.S. Food and Drug Administration is announcing several actions to protect public health related ...
read more
Pfizer announced it will make a $465 million investment to build a sterile injectable pharmaceutical production facility in Portage, Michigan.
read more
Ology Bioservices and Rafa Laboratories announced they received full approval from the FDA for the Atropine Injection, 2mg/0.7mL, Single-Dose Autoinjector.
read more
Pharmaceutical Product Development (PPD) has named Ron Garrow executive vice president and chief human resource officer.
read more
Purdue Pharma has announced leadership changes to the company’s Board of Directors and Executive Committee effective immediately.
read more
STA Pharmaceutical and Antengene Corporation recently announced a strategic partnership for the CMC development and manufacturing of innovative oncology drugs
read more
Lannett announced that it launched four products in June 2018, bringing to seven the total number of products launched since January 1, 2018.
read more
Axol Bioscience launch their Human iPSC-derived Atrial Cardiomyocytes for the discovery and development of novel treatments and advancing our understanding of cardiovascular disease.
read more